Senior Executive Joins IntelGenx Technologies Corp. Management Team

May 29, 2007

Saint Laurent, Quebec. -(CCNMatthews – May 29, 2007) - IntelGenx Technologies Corporation (OTCBB:IGXT) announced today the appointment of Taylor Hutchison as Chief Financial Officer.

Taylor Hutchison is a Chartered Accountant, Certified Public Accountant, and holds an M.B.A. from Concordia University in Montreal. Most recently he was a consultant for two public companies where he oversaw the consolidation, preparation of financial statements, and coordinated the annual and quarterly reporting. From 2002 to 2004, he was the Chief Financial Officer of Organix Corporation, a Canadian holding company. Since 2002 he has been lecturing, part time, at Concordia University.

“We are very pleased to have Taylor join IntelGenx’ executive team. Taylor has a strong financial and managerial background and his experience will play an important part in managing the growth of our company,” said Dr. Horst Zerbe, President and Chief Executive Officer of Intelgenx Technologies Corp.


IntelGenx Corp. is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. The company’s research and development pipeline includes products for the treatment of osteoarthritis, pain management, hypertension, and smoking cessation.
Since January 2007, IntelGenx has been trading on the OTC.BB.

Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995

Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.


IntelGenx Corp.
Dr. Horst G. Zerbe, President and CEO
T: 514-331-7440 (ext. 201)
F: 514-331-0436


The OTC.BB and OSC have not reviewed and do not accept responsibility for the adequacy or accuracy of this release.